International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 1 , Pages 119-124 , 1 May 2010

A 10-Year Retrospective Review of a Nonrandomized Cohort of 458 Patients Undergoing Radical Radiotherapy or Cystectomy in Yorkshire, UK

  • Nicholas P. Munro, Ph.D.

      Affiliations

    • Department of Urology, Mid Yorkshire NHS Trust, Pinderfields Hospital, Aberford Road, Wakefield, UK
    • Corresponding Author InformationReprint requests to: Nicholas P. Munro, Ph.D., 48 Franklin Road, Harrogate, North Yorkshire, UK, HG1 5EE. Tel: (+44) 1423-817166 (land) or (+44) 794104-1732 (mobile)
    • ,
  • Subramnian K. Sundaram, M.S.

      Affiliations

    • Department of Urology, Mid Yorkshire NHS Trust, Pinderfields Hospital, Aberford Road, Wakefield, UK
    • ,
  • Philip M.T. Weston, M. Chir.

      Affiliations

    • Department of Urology, Mid Yorkshire NHS Trust, Pinderfields Hospital, Aberford Road, Wakefield, UK
    • ,
  • Lesley Fairley, Ph.D.

      Affiliations

    • Northern and Yorkshire Cancer Registry and Information Service, St. James's Hospital, Leeds, UK
    • ,
  • Simon C.W. Harrison, M.Chir.

      Affiliations

    • Department of Urology, Mid Yorkshire NHS Trust, Pinderfields Hospital, Aberford Road, Wakefield, UK
    • ,
  • David Forman, Ph.D.

      Affiliations

    • Northern and Yorkshire Cancer Registry and Information Service, St. James's Hospital, Leeds, UK
    • ,
  • Rohit Chahal, M.S.

      Affiliations

    • Department of Urology, Mid Yorkshire NHS Trust, Pinderfields Hospital, Aberford Road, Wakefield, UK

Received 30 December 2008 ,Revised 30 March 2009 ,Accepted 9 April 2009.

References 

  1. UK Bladder Cancer mortality statistics. 2005. Accessed 2008 at info.cancerresearchuk.org/cancerstats/.
  2. Stenzl A, Cowan NC, De Santis M, et al. Guidelines on bladder cancer: muscle invasive and metastatic. Arnhem: Drukkerij. 2008;
  3. Chahal R, Sundaram SK, Iddenden R, et al. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. Eur Urol. 2003;43:246–257
  4. Period and cohort life expectancy tables. 2008. Accessed 2008 at http://www.stattistics.gov.uk/statbase.
  5. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol. 2001;19:666–675
  6. Chung PW, Bristow RG, Milosevic MF, et al. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer. Urol Oncol. 2007;25:303–309
  7. Bell CR, Lydon A, Kernick V, et al. Contemporary results of radical radiotherapy for bladder transitional cell carcinoma in a district general hospital with cancer-centre status. BJU Int. 1999;83:613–618
  8. Bloom HJ, Hendry WF, Wallace DM, et al. Treatment of T3 bladder cancer: Controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Br J Urol. 1982;54:136–351
  9. Duncan W, Quilty PM. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol. 1986;7:299–310
  10. Fossa SD, Waehre H, Aass N, et al. Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients. Cancer. 1993;72:3036–3043
  11. Waehre H, Ous S, Klevmark B, et al. A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer. Cancer. 1993;72:3044–3051
  12. Scrimger RA, Murtha AD, Parliament MB, et al. Muscle-invasive transitional cell carcinoma of the urinary bladder: A population-based study of patterns of care and prognostic factors. Int J Radiat Oncol Biol Phys. 2001;51:23–30
  13. Millar JL, Frydenberg M, Toner G, et al. Management of muscle-invasive bladder cancer in Victoria, 1990–1995. ANZ J Surg. 2006;76:113–119
  14. Kotwal S, Choudhury A, Johnston C, et al. Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center. Int J Radiat Oncol Biol Phys. 2008;70:456–463
  15. Shelley MD, Barber J, Wilt T, et al. Surgery versus radiotherapy for muscle invasive bladder cancer. Cochrane Database Syst Rev. 2002;(1):CD002079
  16. ABC-collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol. 2005;48:202–205
  17. Suttmann H, Kamradt J, Lehmann J, et al. Improving the prognosis of patients after radical cystectomy. Part I: the role of lymph node dissection. BJU Int. 2007;100:1221–1224
  18. Suttmann H, Kamradt J, Lehmann J, et al. Improving the prognosis of patients after radical cystectomy. Part II: the role of perioperative chemotherapy. BJU Int. 2007;100:1225–1228
  19. Nuttall MC, van der Meulen J, McIntosh G, et al. Changes in patient characteristics and outcomes for radical cystectomy in England. BJU Int. 2005;95:513–516
  20. Rodel C, Weiss C, Sauer R. Trimodality treatment and selective organ preservation for bladder cancer. J Clin Oncol. 2006;24:5536–5544

 Conflict of interest: none.

PII: S0360-3016(09)00648-8

doi: 10.1016/j.ijrobp.2009.04.050

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 1 , Pages 119-124 , 1 May 2010

Article Tools

* Image Usage & Resolution